Skip to content

Public FDA record

Z-1834-2024: Reagent Test Strips for Blood, Urobilinogen, Bilirubin, Protein, Nitrite, Ketones, Ascorbic Acid, Glucose

Recall record Z-1834-2024 for Macherey Nagel Gmbh & Co. Kg. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1834-2024
Company in FDA record
Macherey Nagel Gmbh & Co. Kg
FDA classification date
May 16, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The reason for the recall is one of the test pads, for the parameter leukocytes, was missing on some of the test strips. The issue was identified by a consumer by way of a Henry Schein Inc. (HSI) customer complaint. This problem can potentially result in the possibility that the parameter leucocytes (a non-specific marker for urinary track infections and an indicator for inflammatory renal processes) is interpreted instrumentally as a false negative. The following HSI item number and lot number were affected: Urispec 11-Way, #102-2285, LOT 65402.

Source facts

Action
On April4, 2024 URGENT FIELD SAFETY NOTICE letters were sent to direct consignees instructing them to do the following: For distributors: 1. The product named in this safety information must not longer be sold. 2. Confirm the receipt of the information with the attached confirmation of receipt form by April 19, 2024. 3. Pass this safety information on to customers of the affected products. 4. Have the receipt of the information confirmed with the attached confirmation of receipt form. Forward the confirmation forms to our attention using the contact information following. For users: 1. If you have a product Urispec 11-Way, #102-2285, LOT 65402, please check if the leucocytes test pad is present before use of the test strips. 2. Pass the information on to other people and departments who may be working with the product Urispec 11-Way, #102-2285, LOT 65402. 3. Confirm the receipt of the information with the attached confirmation of receipt form by April 19, 2024. 4. If your product is affected, please send the product to your local distributor and arrange for replacement or contact MACHEREY-NAGEL directly. Please make sure in your organization that all users of the above products and other persons to be informed become aware of this Urgent Field Safety Notice. Please keep this information at least until all measures have been completed. Contact persons: Contact for sales / marketing: Dr. Sarah Geenen Product Management Rapid Tests Email: sgeenen@mn-net.com Tel.: +49-(0)2421 969 340, Regulatory contact: Dr. Markus Meusel QAM, Manager Regulatory Affairs Email: mmeusel@mn-net.com Tel. +49 (0) 2421 969 210.
Initiated
2024-04-04
Root cause
Under Investigation by firm
Distribution
US Nationwide distribution in the states of CO, FL, IN, NV, TX.
Recall number
Z-1834-2024
Recall status
Open, Classified
CDRH record ID
207241
FDA classified
2024-05-16
Recall event number
94454

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗